MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heidel, S. M.
Right arrow Articles by Jefcoate, C. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heidel, S. M.
Right arrow Articles by Jefcoate, C. R.

Vol. 54, Issue 6, 1000-1006, December 1998

Bone Marrow Stromal Cells Constitutively Express High Levels of Cytochrome P4501B1 that Metabolize 7,12-Dimethylbenz[a]anthracene

Shawn M. Heidel, Charles J. Czuprynski, and Colin R. Jefcoate

The Center for Environmental Toxicology (S.M.H., C.J.C., C.R.J.), Department of Pathobiological Sciences (S.M.H., C.J.C.), and Department of Pharmacology (C.R.J.), University of Wisconsin, Madison, Wisconsin 53706

The polycyclic aromatic hydrocarbon 7,12-dimethylbenz[a]anthracene (DMBA) is a potent carcinogen that produces immunotoxic effects in bone marrow. Here, we show that bone marrow stromal cells metabolize DMBA to such products as 3,4-dihydrodiol, the precursor to the most mutagenic DMBA metabolite. The BMS2 bone marrow stromal cell line constitutively expressed higher levels of CYP1B1 protein and mRNA than C3H10T1/2 mouse embryo fibroblasts. BMS2 cells also produced a DMBA metabolite profile that was consistent with CYP1B1 activity. Treatment with the potent aryl hydrocarbon receptor (AhR) ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induced a ~2-fold increase in CYP1B1 mRNA, protein, and activity in BMS2 cells. Two forms of the AhR (97 and 104 kDa) and the AhR nuclear translocator were detected in BMS2 cells. The AhR translocated to the nucleus after treatment with TCDD or DMBA but was ~5 times slower with DMBA. Primary bone marrow stromal (BMS) cell cultures established from AhR-/- mice showed similar basal CYP1B1 expression and activity as cell cultures established from heterozygous littermates or C57BL/6 mice. However, primary BMS cells from AhR-/- mice did not exhibit increased CYP1B1 protein expression after incubation with TCDD. BMS cells therefore constitutively express functional CYP1B1 that is not dependent on the AhR. This contrasts with embryo fibroblasts from the same mouse strain, in which basal CYP1B1 expression is AhR dependent. We therefore conclude that bone marrow toxicity may be mediated by CYP1B1-dependent DMBA metabolism, which is regulated by factors other than the AhR.

Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Mol. Pharmacol.Home page
S. Uno, T. P. Dalton, N. Dragin, C. P. Curran, S. Derkenne, M. L. Miller, H. G. Shertzer, F. J. Gonzalez, and D. W. Nebert
Oral Benzo[a]pyrene in Cyp1 Knockout Mouse Lines: CYP1A1 Important in Detoxication, CYP1B1 Metabolism Required for Immune Damage Independent of Total-Body Burden and Clearance Rate
Mol. Pharmacol., April 1, 2006; 69(4): 1103 - 1114.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
J. Gao, F. T. Lauer, S. Dunaway, and S. W. Burchiel
Cytochrome P450 1B1 Is Required for 7,12-Dimethylbenz(a)-anthracene (DMBA) Induced Spleen Cell Immunotoxicity
Toxicol. Sci., July 1, 2005; 86(1): 68 - 74.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S. Uno, T. P. Dalton, S. Derkenne, C. P. Curran, M. L. Miller, H. G. Shertzer, and D. W. Nebert
Oral Exposure to Benzo[a]pyrene in the Mouse: Detoxication by Inducible Cytochrome P450 Is More Important Than Metabolic Activation
Mol. Pharmacol., May 1, 2004; 65(5): 1225 - 1237.
[Abstract] [Full Text]

Home page
 Mol. Pharmacol.Home page
T. J. Page, S. O'Brien, C. R. Jefcoate, and C. J. Czuprynski
7,12-Dimethylbenz[a]anthracene Induces Apoptosis in Murine Pre-B Cells through a Caspase-8-Dependent Pathway
Mol. Pharmacol., August 1, 2002; 62(2): 313 - 319.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
K. K. Mann, S. Doerre, J. J. Schlezinger, D. H. Sherr, and S. Quadri
The Role of NF-{kappa}B as a Survival Factor in Environmental Chemical-Induced Pre-B Cell Apoptosis
Mol. Pharmacol., February 1, 2001; 59(2): 302 - 309.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
S. M. Heidel, P. S. MacWilliams, W. M. Baird, W. M. Dashwood, J. T. M. Buters, F. J. Gonzalez, M. C. Larsen, C. J. Czuprynski, and C. R. Jefcoate
Cytochrome P4501B1 Mediates Induction of Bone Marrow Cytotoxicity and Preleukemia Cells in Mice Treated with 7,12-Dimethylbenz[a]anthracene
Cancer Res., July 1, 2000; 60(13): 3454 - 3460.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
S. E. Shehin, R. O. Stephenson, and W. F. Greenlee
Transcriptional Regulation of the Human CYP1B1 Gene. EVIDENCE FOR INVOLVEMENT OF AN ARYL HYDROCARBON RECEPTOR RESPONSE ELEMENT IN CONSTITUTIVE EXPRESSION
J. Biol. Chem., March 15, 2000; 275(10): 6770 - 6776.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S. M. Heidel, K. Holston, J. T.M. Buters, F. J. Gonzalez, C. R. Jefcoate, and C. J. Czupyrynski
Bone Marrow Stromal Cell Cytochrome P4501B1 Is Required for Pre-B Cell Apoptosis Induced by 7,12-Dimethylbenz[a]anthracene
Mol. Pharmacol., December 1, 1999; 56(6): 1317 - 1323.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics